ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
ABVC | US
Overview
Corporate Details
- ISIN(s):
- US00091F1066
- LEI:
- Country:
- United States of America
- Address:
- 44370 OLD WARM SPRINGS BLVD., 94538 FREMONT
- Website:
- https://abvcpharma.com/
- Sector:
- Manufacturing
Description
ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-05-16 18:30 |
DEFINITIVE PROXY STATEMENT
|
English | 1.7 MB | ||
| 2025-05-16 18:14 |
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
|
English | 4.8 MB | ||
| 2025-05-16 18:07 |
POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1
|
English | 4.8 MB | ||
| 2025-05-14 18:30 |
AMENDMENT TO FORM 8-K
|
English | 82.0 KB | ||
| 2025-05-14 10:30 |
AMENDMENT NO. 2 TO FORM 8-K
|
English | 96.8 KB | ||
| 2025-05-06 18:30 |
CURRENT REPORT
|
English | 77.9 KB | ||
| 2025-05-02 18:30 |
FORM FORM 8-K/A
|
English | 76.8 KB | ||
| 2025-05-01 10:00 |
CURRENT REPORT
|
English | 104.6 KB | ||
| 2025-04-30 18:41 |
QUARTERLY REPORT
|
English | 2.2 MB | ||
| 2025-04-30 18:30 |
CURRENT REPORT
|
English | 131.5 KB | ||
| 2025-04-24 20:30 |
PRELIMINARY PROXY STATEMENT
|
English | 144.9 KB | ||
| 2025-04-16 15:42 |
AMENDMENT NO. 1 TO FORM 8-K
|
English | 105.0 KB | ||
| 2025-04-15 18:30 |
CURRENT REPORT
|
English | 102.3 KB | ||
| 2025-04-15 18:23 |
ANNUAL REPORT
|
English | 8.2 MB | ||
| 2025-03-31 19:00 |
NOTIFICATION OF LATE FILING
|
English | 11.1 KB |
Automate Your Workflow. Get a real-time feed of all ABVC BIOPHARMA, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ABVC BIOPHARMA, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ABVC BIOPHARMA, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
